At the heart of this debate lies the evolutionary principle of natural selection, whose strength diminishes after an organism reaches reproductive maturity. This decline in selective pressure implies that aging need not be programmed actively; rather, it may be a secondary consequence of the gradual breakdown of cellular repair mechanisms. Damage accrues in the form of DNA mutations, protein misfolding, epigenetic alterations, and mitochondrial dysfunction, all contributing to systemic entropy and functional decline. This perspective sharply contrasts with programmed aging theories, which posit that aging is a genetically encoded process aimed at an evolutionary purpose, such as population control or resource allocation.

Recent investigations utilizing cross-species comparisons have provided compelling evidence for the stochastic damage model. Longevity in mammals correlates strongly with enhanced capacities for DNA repair, suggesting that an organism’s ability to maintain genomic integrity is a pivotal determinant of lifespan. Species with exceptional longevity, such as certain bats and whales, exhibit robust DNA repair pathways and superior proteostasis networks, which effectively mitigate the accumulation of molecular damage over time. These findings indicate that lifespan extension strategies might be more successful if they focus on augmenting cellular maintenance rather than targeting hypothetical aging programs.

The precision of modern aging clocks stems from the integration of multiple molecular markers, including DNA methylation patterns, transcriptomic changes, and proteomic alterations. These clocks provide a snapshot of biological age by quantifying deviations from youthful molecular states. While the accuracy of these clocks is remarkable, their predictive power does not necessarily imply underlying biological programming. Instead, they appear to measure the composite burden of stochastic damage that accumulates as maintenance mechanisms become less efficient with age. Thus, aging clocks serve as powerful tools for quantifying biological age and healthspan but should not be misconstrued as proof of a programmed aging process.

In addressing the molecular basis of aging, it is critical to recognize the role of cellular homeostasis and repair systems. Autophagy, ubiquitin-proteasome degradation, DNA repair pathways like nucleotide excision repair and homologous recombination, and antioxidant defenses collectively form a network of maintenance activities that preserve cellular integrity. As organisms age, the efficiency of these systems declines, leading to the gradual accumulation of molecular errors. This decline can be influenced by environmental factors, genetic background, and stochastic events, highlighting the complex interplay that governs aging dynamics at the cellular level.

From an evolutionary standpoint, the weakening of selective pressures post-reproduction means deleterious mutations and suboptimal maintenance can accumulate without immediate consequence to fitness. The pleiotropic effects of genes beneficial early in life but harmful later on (antagonistic pleiotropy) and the accumulation of late-acting deleterious mutations provide further theoretical frameworks accounting for aging without invoking a programmed mechanism. This evolutionary backdrop supports the stochastic error accumulation model, framing aging as an emergent property of imperfect biology rather than a predetermined genetic program.

The implications of viewing aging through the lens of stochastic damage rather than a program extend profoundly into therapeutic strategies for healthy aging. Geroprotective interventions might find more success by targeting the enhancement of repair and maintenance pathways, rather than attempting to “turn off” an elusive aging program. Approaches such as boosting DNA repair enzymes, improving mitochondrial quality control, promoting proteostasis, and reducing oxidative stress are emerging as promising avenues to delay the functional decline associated with aging.

Furthermore, the application of aging clocks in clinical and research settings opens new opportunities for personalizing anti-aging therapies. By precisely measuring biological age and its deviation from chronological age, clinicians can monitor the effectiveness of interventions designed to bolster cellular maintenance. The ability to track dynamic changes in biological age could facilitate tailored treatments, optimizing healthspan extension on an individual level.

Importantly, the notion of system-wide entropy in biological aging underscores that aging is not localized but affects multiple cellular and tissue systems simultaneously. This multifactorial decline converges to reduce organismal resilience, increasing susceptibility to age-related diseases such as cancer, neurodegeneration, and metabolic disorders. The systemic nature of aging suggests that successful long-term interventions will require a comprehensive approach addressing multiple aspects of cellular and molecular maintenance.

Technological advances in genomics, proteomics, and imaging have bolstered our capacity to dissect the aging process with unprecedented resolution. These innovations enable the identification of critical nodes within maintenance networks that fail during aging. For example, recent data implicate specific DNA repair enzymes and stress response factors in preserving longevity, providing concrete molecular targets for intervention. Continued integration of multi-omics data will deepen mechanistic understanding and reveal synergistic pathways that could be harnessed therapeutically.

The cross-species comparative analysis of aging mechanisms adds another dimension to our understanding of longevity determinants. Studying long-lived species that naturally maintain high DNA repair fidelity and low damage accumulation offers models for therapeutic mimicry in humans. Such comparative biology approaches can identify conserved pathways that promote lifespan extension, guiding drug development and lifestyle modifications aimed at sustaining cellular health.

Despite the substantial progress, much remains to be elucidated about the heterogeneity of aging processes across tissues and individuals. Understanding why certain cell types or organs succumb earlier to damage accumulation could refine intervention timing and specificity. Additionally, decoding how stochastic molecular errors translate into macroscopic phenotypes like frailty will be critical for developing comprehensive aging models.

In summary, while aging clocks offer valuable insights by quantifying biological age, their existence does not confirm the presence of an inherent aging program. Rather, they measure the cumulative burden of molecular damage accrued via imperfect maintenance mechanisms, shaped over evolutionary time by relaxed selective pressures. Recognizing aging as a stochastic, error-driven process shifts the paradigm towards enhancing resilience and repair capacity to promote healthy lifespan extension in humans.

The convergence of molecular biology, evolutionary theory, and aging clock technology heralds a new era in aging research. By embracing the complexity and stochastic nature of aging, researchers and clinicians can devise more effective strategies for geroprotection grounded in mechanistic understanding. Ultimately, dismantling the myth of programmed aging in favor of a damage accumulation framework empowers the development of interventions that may one day transform human healthspan and vitality.

Subject of Research: Aging mechanisms and the debate over programmed versus stochastic causes of aging; evaluation of aging clocks as biomarkers of biological age.

Article Title: Aging by the clock and yet without a program.

Article References:
Meyer, D.H., Maklakov, A.A. & Schumacher, B. Aging by the clock and yet without a program. Nat Aging (2025). https://doi.org/10.1038/s43587-025-00975-2

Image Credits: AI Generated

Traditionally, the process of cellular repair has been thought to rely heavily on lysosomes, tiny organelles responsible for the gradual digestion and recycling of damaged proteins and organelles. These lysosomal pathways, while efficient for routine maintenance, are inadequate in the face of acute injury when rapid reprogramming of cells is essential. The new data demonstrate that cells can bypass slow, intracellular degradation pathways by jettisoning unwanted cellular components outside the cell environment, enabling faster cellular transformation that is critical for healing.

In their study, published online in Cell Reports, the researchers used a mouse model of stomach injury to observe this phenomenon in unprecedented detail. The stomach’s epithelial cells—key players in protecting and regenerating the gastric lining—were seen creating transient cavities or pores in their membranes, through which large amounts of cellular debris were expelled. This intense cellular purging was observed occurring simultaneously in multiple cells, suggesting that cathartocytosis is a coordinated and fundamental component of the regenerative response.

Jeffrey W. Brown, MD, PhD, assistant professor of medicine at WashU Medicine and the study’s first author, described the process as a necessary decluttering event. “The mature cellular machinery of a differentiated cell, while well-suited for its usual tasks, becomes an obstacle during injury repair,” Brown explained. “Cathartocytosis is a rapid, albeit somewhat messy, shortcut cells use to shed this machinery so they can quickly revert to a primitive, stem cell-like state ready for proliferation and repair.”

This mechanism represents a new layer within the regenerative framework known as paligenosis, previously characterized as the reprogramming of mature cells into stem-like progenitors able to regenerate damaged tissues. Jason C. Mills, MD, PhD, senior author and now at Baylor College of Medicine, first described paligenosis in 2018. The current work builds on that foundation by revealing that cathartocytosis is a key step within this process, facilitating the massive cellular remodeling required for tissue regeneration.

Electrifyingly, the discovery that cells actively eject waste into their external environment challenges previously held assumptions that all cellular remodeling must occur in enclosed intracellular compartments. Early observations of extracellular debris during paligenosis were originally discounted but have now been recognized as a purposeful and widespread biological phenomenon. This extracellular purging presumably serves to accelerate reprogramming by physically removing molecular roadblocks that would otherwise slow the cell’s transformation.

Despite the benefits of cathartocytosis in acute injury repair, the researchers caution about its potential downsides. The process is fast but disorderly, releasing cellular waste products into the surrounding tissue that may exacerbate local inflammation. In cases of chronic injury or infection, such as persistent Helicobacter pylori infection in the stomach, ongoing cathartocytosis may contribute to a-inflammatory microenvironment, fueling cycles of damage and repair that increase the risk of oncogenic mutations and cancer development.

Indeed, the relationship between cathartocytosis and cancer arises as a double-edged sword. While the mechanism underlies critical regenerative responses, its dysregulation may enable precancerous cells to thrive. As stem cell-like cells multiply to repair damage, those harboring mutations gain a proliferative advantage in inflamed tissues, potentially seeding tumorigenesis. The expelled cellular debris itself could indicate ongoing pathological processes and serve as an early marker of neoplastic progression.

Recognizing this, Brown and his collaborators have developed a novel antibody capable of binding to waste products ejected during cathartocytosis. This tool offers the exciting potential to detect and quantify cathartocytosis in tissue samples, facilitating early diagnosis of precancerous states and allowing for intervention before cancer fully develops. The antibody could become a critical instrument in gastrointestinal cancer surveillance and even in monitoring inflammatory conditions linked to chronic tissue injury.

Early detection aside, the study suggests future therapeutic avenues to modulate cathartocytosis. By better understanding this cellular cleanse, it may be possible to enhance its beneficial regenerative effects while mitigating its contribution to chronic inflammation and tumorigenesis. For example, selective inhibition of cathartocytosis in damage-prone or inflammation-susceptible tissues might reduce cancer risk without compromising healing.

More broadly, although this investigation focused on stomach epithelial cells, the authors speculate that cathartocytosis likely operates in other organ systems following injury. The universality of reprogramming to stem cell-like states in regeneration suggests that similar waste-clearing mechanisms could be vital in healing processes across the liver, pancreas, kidneys, and beyond, setting the stage for broad biomedical impact.

This discovery redefines our understanding of cellular plasticity and injury response, illuminating how cells navigate the delicate balance between repair and disease. The identification of cathartocytosis not only enhances the molecular narrative of regeneration but also offers practical insights for diagnosing and treating cancers with inflammatory origins. As research continues, cathartocytosis may emerge as a cornerstone concept in regenerative biology and oncology.

Subject of Research: Cellular mechanisms of injury response and regeneration

Article Title: Cathartocytosis: jettisoning of cellular material during reprogramming of differentiated cells

News Publication Date: 20-Jul-2025

Web References:

• Publisher DOI link: http://dx.doi.org/10.1016/j.celrep.2025.116070
• Washington University Division of Gastroenterology: https://gastro.wustl.edu/
• WashU Medicine: https://medicine.washu.edu/

References:
Brown JW, Lin X, Nicolazzi GA, Liu X, Nguyen T, Radyk MD, Burclaff J, Mills JC. Cathartocytosis: jettisoning of cellular material during reprogramming of differentiated cells. Cell Reports. Online July 20, 2025. DOI: 10.1016/j.celrep.2025.116070.

Image Credits: Jeffrey Brown

Keywords: Stomach, Cellular regeneration, Paligenosis, Cathartocytosis, Stem cell reprogramming, Cellular waste jettison, Gastric injury, Chronic inflammation, Cancer risk, Helicobacter pylori, Regenerative medicine, Cell Reports

Precision gene editing aims to rectify specific mutations that lead to genetic diseases. However, a significant hurdle has been the low efficiency of homologous recombination (HR), which often fails to operate outside of highly controlled conditions. In normal cellular environments, CRISPR-Cas9 generates double-strand breaks (DSBs) intended for gene editing. Unfortunately, these breaks are typically repaired via the error-prone method known as non-homologous end joining (NHEJ), leading to unwanted insertions or deletions that can complicate therapeutic intentions. This research offers a novel approach to shift the balance towards more accurate repair mechanisms.

The inspiration for this research stemmed from established knowledge that activation of autophagy alters cellular repair dynamics. Autophagy is known for its role in degrading cellular components in response to stress or nutrient deprivation. The KRICT team sought to explore whether inducing autophagy could favor homologous recombination over the nonspecific errors introduced through NHEJ. In pursuit of this idea, they found that autophagy induction via nutrient deprivation or the inhibition of the mechanistic target of rapamycin (mTOR) significantly improved HR-based CRISPR-Cas9 efficiencies, with enhancements reaching up to threefold in diverse test scenarios.

A multi-faceted experimental approach was employed, validating the findings across several cell lines as well as patient-derived cells harboring genetic mutations. Notably, the research explored the impact of these enhancements within living organisms, showcasing the crucial applicability of their findings beyond in vitro studies. The intentional triggering of autophagy proved to lead to a notable increase in homologous recombination events, signaling a profound shift in the methodology of gene editing.

The results presented by Dr. Nam and her collaborators reveal a promising strategy for researchers facing challenges with inconsistent editing by offering an improved mechanism. Experimentation demonstrated clear variations in HR efficiency, often yielding up to 3.1 times the success rate across various gene targets and DNA insertion sizes when autophagy was in play. Conversely, cells that were incapable of undergoing autophagy did not show any improvements, underscoring autophagy’s crucial role in this enhanced precision.

Moreover, this innovative approach showed versatility across different versions of CRISPR technology, including nickase Cas9 (nCas9) and dead Cas9 (dCas9). The implications of these findings suggest that this technique could become a staple across various gene editing platforms, increasing its accessibility for broader applications in genetic therapies. Additional analyses indicated that cellular autophagy not only boosts HR success but also elevates the presence of HR-associated DNA repair proteins within the CRISPR-Cas9 complex, leading to more precise gene editing outcomes.

The implications regarding real-world applications of this research were further explored through testing in live animal models. In one instance, gene editing efforts executed within the mouse retina led to approximately a threefold increase in editing efficiency when autophagy was induced. By validating these findings in both cultured cells and living organisms, the researchers set the stage for potential clinical applications of the technique, a hallmark of translational research.

In particular, the research team focused on patient-derived cells linked to the MPZL2 gene, a mutation associated with hearing loss, which demonstrated increased expression rates of the corrected gene due to the methodology employed. Such findings extend the hope that inducing autophagy can facilitate widespread applications in gene therapy and treatment strategies.

The significance of this work lies in its contributions to the broader field of gene editing. By showcasing that autophagy can meaningfully improve the accuracy of genome editing in human cells and animal models, Dr. Nam and her team have ushered in a new era for gene therapies that at once improve safety and efficacy. Commenting on the breakthrough, Dr. Nam noted that leveraging autophagy represents a strategic move to tackle underlying limitations currently faced by existing gene editing methodologies.

This research reflects a shift in understanding the cellular processes underlying gene editing technologies and opens unparalleled avenues for the development of therapeutics involving CRISPR methodologies. KRICT’s president, Young-Kuk Lee, emphasized the importance of this achievement, labeling it a significant step towards enhancing genome editing technologies.

Published in Nucleic Acids Research, this study demonstrates a pivotal advancement in gene editing technologies that could empower the design of more effective therapies for genetic disorders. With the groundwork laid by this research, the potential applications and implications for clinical practice become increasingly tangible, marking an essential milestone in the evolution of precision medicine.

As the field of gene editing continues to grow, this research emphasizes the importance of looking toward internal processes like autophagy as critical mechanisms for enhancing current technologies. It signals a promising future for genetic therapy, positioning researchers to better tackle the challenges associated with genetic diseases through more efficient and targeted approaches.

In conclusion, the work led by KRICT not only redefines the landscape of gene editing but also provides a clear path for future investigations aimed at refining therapeutic interventions for a range of genetic conditions. The potential to manipulate internal cellular mechanisms such as autophagy signals a paradigm shift that could greatly enhance the accuracy and safety of gene editing techniques internationally.

Subject of Research: Induction of autophagy to enhance CRISPR-Cas9 gene editing efficiency
Article Title: Autophagy induction enhances homologous recombination-associated CRISPR–Cas9 gene editing
News Publication Date: 15-Apr-2025
Web References: Nucleic Acids Research DOI
References: N/A
Image Credits: Credit: Korea Research Institute of Chemical Technology (KRICT)

Keywords

Autophagy, Gene Editing, CRISPR-Cas9, Homologous Recombination, Precision Medicine, Nucleic Acids Research.